封面
市場調查報告書
商品編碼
1623840

過敏診斷和治療市場規模、佔有率、成長分析、按類型、按過敏原類型、按測試類型、按地區 - 行業預測,2025-2032

Allergy Diagnostics and Therapeutics Market Size, Share, Growth Analysis, By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled), By Test Type, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023年過敏診斷和治療市場規模為306.9億美元,從2024年的333.9億美元成長到2032年的655.5億美元,複合年成長率預計將成長8.8%。

由於幾個關鍵因素,全球過敏診斷市場預計將出現強勁成長。環境污染的加劇和醫療保險的普及是這項擴張的重要因素。過敏性疾病的日益普及對經濟產生了重大影響,加上過敏診斷投資的增加進一步推動了市場的成長。生活方式的改變,特別是不健康的加工食品的消費和污染的增加,對這一趨勢產生了重大影響。此外,食物過敏的快速增加往往是由於飲食意識低下所致,凸顯了對過敏診斷的需求不斷成長。行動醫療(mHealth)技術的整合以及對創新治療和先進診斷策略的持續研究正在加強技術進步,有望加強過敏診斷領域並帶來巨大的市場機會。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制因素和挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析
  • 案例研究分析

過敏診斷和治療市場規模:按類型

  • 市場概況
  • 診斷
    • 裝置
    • 消耗品
    • 服務
  • 治療藥物
    • 抗組織胺藥物
    • 減充血劑
    • 皮質類固醇
    • 肥大細胞穩定劑
    • 白三烯抑制劑
    • 鼻用抗膽鹼能藥物
    • 免疫調節劑
    • 腎上腺素
    • 免疫療法

過敏診斷和治療市場規模:按過敏原類型

  • 市場概況
  • 食品
    • 乳製品
    • 家禽產品
    • 堅果
    • 花生
    • 貝類
    • 小麥
    • 大豆
    • 其他食物過敏原
  • 吸入
  • 藥品
  • 其他過敏原

按測試類型分類的過敏診斷和治療市場規模

  • 市場概況
  • 體內試驗
    • 皮膚點刺試驗
    • 皮內測試
    • 斑貼試驗
  • 體外試驗

過敏診斷與治療市場規模

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024年)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2022-2024)

主要企業簡介

  • Thermo Fisher Scientific Inc.(US)
  • Siemens Healthineers(Germany)
  • Danaher(US)
  • Omega Diagnostics Group PLC(UK)
  • bioMerieux SA(France)
  • Romer Labs Division Holding(Austria)
  • EUROIMMUN Medizinische Labordiagnostika AG(Germany)
  • HollisterStier Allergy(US)
  • NEOGEN Corporation(US)
  • Eurofins Scientific(Luxembourg)
  • Minaris Medical America Inc.(US)
  • HOB Biotech Group Corp. Ltd.(China)
  • HYCOR Biomedical(US)
  • R-Biopharm AG(Germany)
  • AESKU.GROUP GmbH(Germany)
  • ACON Laboratories Inc.(US)
  • Lincoln Diagnostics Inc.(US)
  • Astra Biotech GmbH(Germany)
  • ERBA Group(UK)

結論和建議

簡介目錄
Product Code: SQMIG35H2183

Allergy Diagnostics and Therapeutics Market size was valued at USD 30.69 Billion in 2023 and is poised to grow from USD 33.39 Billion in 2024 to USD 65.55 Billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global allergy diagnostics market is poised for robust growth driven by several key factors. Rising environmental pollution and greater healthcare insurance accessibility are vital contributors to this expansion. The increasing prevalence of allergic diseases, resulting in significant economic impact, combined with heightened investment in allergy diagnostics, further propel market growth. Lifestyle changes, particularly the intake of unhealthy processed foods and rising pollution, are major influencers on this trend. Additionally, the surge in food allergies, often stemming from poor dietary awareness, underscores the growing demand for allergy diagnostics. The integration of mobile health (mHealth) technologies and continuous research into innovative treatments and advanced diagnostic strategies present substantial market opportunities, reinforcing the technological advancements that promise to enhance the allergy diagnostics landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics And Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics And Therapeutics Market Segmental Analysis

Global Allergy Diagnostics and Therapeutics Market is segmented by type, allergen type, test type and region. Based on type, the market is segmented into diagnostics and therapeutics. Based on allergen type, the market is segmented into food, inhaled, drug and other allergens. Based on test type, the market is segmented into in vivo test and in vitro test. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market is significantly driven by the rising prevalence of allergic diseases, especially among urban populations who face a greater risk due to their exposure to environmental pollutants. This heightened incidence not only affects public health but also imposes a substantial economic burden on healthcare systems, as more individuals seek diagnosis and treatment for various allergy-related conditions. As cities continue to grow and pollution levels rise, the demand for effective diagnostic and therapeutic solutions in allergy management will likely increase, further propelling the growth of this market. Consequently, addressing allergies has become a vital public health concern.

Restraints in the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market faces several constraints that may impede its growth trajectory. One significant challenge is the escalating costs associated with allergy diagnostic instruments, which can limit accessibility and affordability for healthcare providers and patients alike. Furthermore, the shortage of trained allergists may exacerbate these issues, hindering effective delivery of diagnostic services. This report delves into various aspects of the allergy diagnostics market, exploring recent developments, regulatory influences, and market dynamics, as well as identifying potential revenue opportunities and technological advancements. For further insights or assistance, please connect with Data Bridge Market Research for expert guidance.

Market Trends of the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market is witnessing a robust upward trend, driven by the rising prevalence of allergic diseases globally. With factors such as urbanization, environmental pollution, and shifting dietary patterns contributing to the surge in allergic conditions, healthcare systems are increasingly focused on effective diagnostic methods and innovative therapeutic solutions. Advancements in technology-ranging from enhanced testing kits to targeted biologics-are improving the accuracy and efficiency of allergy management. This rising awareness and demand for personalized treatment options are propelling market growth, making it essential for stakeholders to adapt to evolving patient needs and environmental challenges in this dynamic landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Study Analysis

Global Allergy Diagnostics and Therapeutics Market Size by Type & CAGR (2024-2032)

  • Market Overview
  • Diagnostics
    • Instruments
    • Consumables
    • Services
  • Therapeutics
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-Cholinergic
    • Immuno-Modulators
    • Epinephrine
    • Immunotherapy

Global Allergy Diagnostics and Therapeutics Market Size by Allergen Type & CAGR (2024-2032)

  • Market Overview
  • Food
    • Dairy Products
    • Poultry Product
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soys
    • Other Food Allergens
  • Inhaled
  • Drug
  • Other Allergens

Global Allergy Diagnostics and Therapeutics Market Size by Test Type & CAGR (2024-2032)

  • Market Overview
  • In Vivo Test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In Vitro Test

Global Allergy Diagnostics and Therapeutics Market Size & CAGR (2024-2032)

  • North America (Type, Allergen Type, Test Type)
    • US
    • Canada
  • Europe (Type, Allergen Type, Test Type)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Allergen Type, Test Type)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Allergen Type, Test Type)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Allergen Type, Test Type)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omega Diagnostics Group PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Romer Labs Division Holding (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EUROIMMUN Medizinische Labordiagnostika AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HollisterStier Allergy (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NEOGEN Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Minaris Medical America Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HOB Biotech Group Corp. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HYCOR Biomedical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • R-Biopharm AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AESKU.GROUP GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ACON Laboratories Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lincoln Diagnostics Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Astra Biotech GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ERBA Group (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations